| Literature DB >> 32276543 |
Sunil Singh1, Sydnie Tran1, Justin Putman1, Hossein Tavana1.
Abstract
IMPACT STATEMENT: Tumor stroma plays an important role in progression of cancers to a fatal metastatic disease. Modern treatment strategies are considering targeting tumor stroma to improve outcomes for cancer patients. A current challenge to develop stroma-targeting therapeutics is the lack of preclinical physiologic tumor models. Animal models widely used in cancer research lack human stroma and are not amenable to screening of chemical compounds for cancer drug discovery. In this review, we outline in vitro three-dimensional tumor models that we have developed to study the interactions among cancer cells and stromal cells. We describe development of the tumor models in a modular fashion, from a spheroid model to a sophisticated organotypic model, and discuss the importance of using correct physiologic models to recapitulate tumor-stromal signaling. These biomimetic tumor models will facilitate understanding of tumor-stromal signaling biology and provide a scalable approach for testing and discovery of cancer drugs.Entities:
Keywords: Tumor microenvironment; breast cancer; cancer-associated fibroblasts; tumor model
Mesh:
Year: 2020 PMID: 32276543 PMCID: PMC7268931 DOI: 10.1177/1535370220917366
Source DB: PubMed Journal: Exp Biol Med (Maywood) ISSN: 1535-3699